Twist Bioscience: Fiscal Q3 Earnings Snapshot

SOUTH SAN FRANCISCO, Calif. (AP) — SOUTH SAN FRANCISCO, Calif. (AP) — Twist Bioscience Corp. (TWST) on Friday reported a loss of $57.4 million in its fiscal third quarter.

The South San Francisco, California-based company said it had a loss of $1.01 per share.

The results beat Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of $1.14 per share.

The maker of synthetic DNA for the biotechnology industry posted revenue of $63.7 million in the period, which also topped Street forecasts. Four analysts surveyed by Zacks expected $60.7 million.

For the current quarter ending in September, Twist Bioscience said it expects revenue in the range of $63 million to $64 million.

The company expects full-year revenue in the range of $241 million to $242 million.


This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on TWST at

Copyright © 2023 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.

Federal News Network Logo

More from WTOP

Log in to your WTOP account for notifications and alerts customized for you.

Sign up